Literature DB >> 12769658

Contributory role of matrix metalloproteinases in cardiovascular remodeling.

S K Gunasinghe1, J Ikonomidis, F G Spinale.   

Abstract

Changes in cardiovascular tissue structure can result in alterations in function. This process occurs as a continuum and can be defined as cardiovascular remodeling. A family of zinc dependent proteases known as the matrix metalloproteinases (MMPs) has been demonstrated to cause tissue remodeling. A number of past studies have demonstrated increased expression and activation of MMPs in both myocardial and vascular remodeling processes. Experimental results support the concept that the MMPs directly contribute to progressive myocardial remodeling post-myocardial infarction and in cardiomyopathic disease. Within the vascular compartment, compelling evidence exists for the contributory role of MMPs in atheromatous plaque rupture and aortic aneurysms. Therefore, the purpose of this review is to examine recent studies of this proteolytic system in the context of cardiovascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12769658     DOI: 10.2174/1568006013337953

Source DB:  PubMed          Journal:  Curr Drug Targets Cardiovasc Haematol Disord        ISSN: 1568-0061


  4 in total

1.  Effects of exercise training on cardiac function and myocardial remodeling in post myocardial infarction rats.

Authors:  Xiaohua Xu; Wenhan Wan; Anthony S Powers; Ji Li; Lisa L Ji; Shunhua Lao; Bryan Wilson; John M Erikson; John Q Zhang
Journal:  J Mol Cell Cardiol       Date:  2007-10-12       Impact factor: 5.000

2.  Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).

Authors:  D Dirk Bonnema; Carson S Webb; Weems R Pennington; Robert E Stroud; Amy E Leonardi; Leslie L Clark; Catherine D McClure; Laura Finklea; Francis G Spinale; Michael R Zile
Journal:  J Card Fail       Date:  2007-09       Impact factor: 5.712

3.  ETA selective receptor antagonism prevents ventricular remodeling in volume-overloaded rats.

Authors:  David B Murray; Ronald McMillan; Gregory L Brower; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

4.  Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.

Authors:  S-L Puhl; A Kazakov; A Müller; P Fries; D R Wagner; M Böhm; C Maack; Y Devaux
Journal:  Br J Pharmacol       Date:  2015-11-16       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.